iShares JPMorgan USD Emerging Markets Bond ETF vs Liquidia Corporation Common Stock — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $91.23 (market cap $12.90B), while Liquidia Corporation Common Stock trades at $33.78 (market cap $2.40B). The key difference: iShares JPMorgan USD Emerging Markets Bond ETF is far larger — about 5.4× Liquidia Corporation Common Stock's market cap, and iShares JPMorgan USD Emerging Markets Bond ETF is more actively traded (8,768,615 versus 2,857,547). Which is the better fit depends on your goals — on Pluang, investors hold iShares JPMorgan USD Emerging Markets Bond ETF for 50 Days and Liquidia Corporation Common Stock for 0 Days on average.
| EMB | LQDA | |
|---|---|---|
Market Cap | $12.90B | $2.40B |
Volume | 8,768,615 | 2,857,547 |
Sector | Fixed Income | Health |
52-Week High | $97.74 | $91.03 |
52-Week Low | $90.14 | $22.02 |
Typical Hold Time | 50 Days | 0 Days |
Enterprise Value | — | $2.30B |
Signals from Pluang's Aura AI — not financial advice
EMB trades at $91.26, up 0.2% on the day, with technical indicators showing a bearish bias as moving averages signal selling pressure. The stock faces resistance near $91-92 while support holds at $90. Recent corporate actions include scheduled dividend payments through October 2026, though key valuation metrics remain unavailable for fundamental assessment.
The outlook remains cautious given the bearish technical setup and limited fundamental visibility. Investment opportunity hinges on future financial disclosures, while risks include market volatility from rising bond yields and emerging market exposure. Analyst sentiment suggests EMB's returns will primarily come from yield rather than price appreciation.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →